Evidence map›Paper›PMID 24341990›Full record

ArticleExperimental eye research2014

A gradient of matrix-bound FGF-2 and perlecan is available to lens epithelial cells.

Weiju Wu, Frederique M Tholozan, Martin W Goldberg, Leon Bowen, Junjie Wu, Roy A Quinlan

Open access · hybridAbstract read
In one paragraph

Article in Experimental eye research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. An Atlas of Heparan Sulfate Proteoglycans in the Postnatal Rat Lens.Investigative ophthalmology & visual science · 2021
    Article
  9. Ultrahigh field MRI determination of water diffusion rates inQuantitative imaging in medicine and surgery · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. β1-integrin controls cell fate specification in early lens development.Differentiation; research in biological diversity
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Weiju WuBiophysical Sciences Institute, School of Biological and Biomedical Sciences, Durham University, South Road, Durham DH1 3LE, United Kingdom.
Frederique M TholozanNETPark Incubator, Thomas Wright Way, Sedgefield, Durham TS21 3FD, United Kingdom.
Martin W GoldbergBiophysical Sciences Institute, School of Biological and Biomedical Sciences, Durham University, South Road, Durham DH1 3LE, United Kingdom.
Leon BowenBiophysical Sciences Institute, Department of Physics, Durham University, Durham DH1 3LE, United Kingdom.
Junjie WuBiophysical Sciences Institute, School of Engineering and Computing Sciences, Durham University, Durham DH1 3LE, United Kingdom.
Roy A QuinlanBiophysical Sciences Institute, School of Biological and Biomedical Sciences, Durham University, South Road, Durham DH1 3LE, United Kingdom. Electronic address: r.a.quinlan@dur.ac.uk.
Durham University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factors play a key role in regulating lens epithelial cell proliferation and differentiation via an anteroposterior gradient that exists between the aqueous and vitreous humours. FGF-2 is the most important for lens epithelial cell proliferation and differentiation. It has been proposed that the presentation of FGF-2 to the lens epithelial cells involves the lens capsule as a source of matrix-bound FGF-2. Here we used immunogold labelling to measure the matrix-bound FGF-2 gradient on the inner surface of the lens capsule in flat-mounted preparations to visualize the FGF-2 available to lens epithelial cells. We also correlated FGF-2 levels with levels of its matrix-binding partner perlecan, a heparan sulphate proteoglycan (HSPG) and found the levels of both to be highest at the lens equator. These also coincided with increased levels of phosphorylated extracellular signal-regulated kinase 1 and 2 (pERK1/2) in lens epithelial cells that localised to condensed chromosomes of epithelial cells that were Ki-67 positive. The gradient of matrix-bound FGF-2 (anterior pole: 3.7 ± 1.3 particles/μm2; equator: 8.2 ± 1.9 particles/μm2; posterior pole: 4 ± 0.9 particles/μm2) and perlecan (anterior pole: 2.1 ± 0.4 particles/μm2; equator: 5 ± 2 particles/μm2; posterior pole: 1.9 ± 0.7 particles/μm2) available at the inner lens capsule surface was measured for the bovine lens. These data support the anteroposterior gradient hypothesis and provide the first measurement of the gradient for an important morphogen and its HSPG partner, perlecan, at the epithelial cell-lens capsule interface.

Indexed as

AnimalsCattleCollagen Type IVEpithelial CellsFibroblast Growth Factor 2Heparan Sulfate ProteoglycansImmunohistochemistryLens Capsule, CrystallineMicroscopy, Electron, ScanningMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PhosphorylationCollagen Type IVFibroblast Growth Factor 2Heparan Sulfate ProteoglycansMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3perlecanERK1/2FGF-2lens capsuleperlecan

Identifiers

PMID24341990
PMCPMC3988982
OpenAlexW1985143853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.